# Triad Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/triad-biotechnology

- Industry: Biotechnology
- Headquarters: San Diego, US
- Total disclosed funding: $12M
- Latest round: Series A (Oct 1, 1999)
- Investors on record: 5

## About

Triad Biotechnology inc. is based in US and operates as a biotechnology company which plans to engineer antimicrobial drug candidates to leverage the availability of microbial genomic information.

## Funding rounds

- Series A, Oct 1, 1999, $12M — Skyline Ventures, GeneChem, Tekla Capital Management, Lombard Odier Asset Management, Hambrecht & Quist

## Investors

- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series A
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series A
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series A
- Lombard Odier Asset Management — Series A
- Hambrecht & Quist (https://capitalatlas.ai/funds/hambrecht-quist) — Series A